In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EuroCMR 2019: Focusing on value, quality and evidence

EuroCMR Congress News

Cardiac Magnetic Resonance


petersen-steffen-erhard-2019.jpgProfessor Steffen Petersen, EACVI Vice President for CMR 2018–2020, explained the focus of this year’s congress: “CMR imaging has been such a fast-moving field over the last decade, but with all the improvements in technology, we are now at the stage where we can position CMR and demonstrate the quality we can provide to patients and show how we can add value with this imaging modality.”

“Throughout EuroCMR 2019, we will focus on what CMR imaging adds to patient management, how patients can benefit and how we can change practice. We will consider the existing and emerging evidence behind established and potential clinical indications. We also need to think about how we best manage limited resources and how the CMR community can demonstrate and quantify the cost effectiveness and value of CMR imaging to inform policymakers and health insurance companies.

The Opening plenary on Friday will have presentations on different topics related to evidence, challenges and innovation. We will touch upon the role of CMR in cardio-oncology, associations with genetics, and new diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy, demonstrating the wide reach of CMR and its further potential in contemporary cardiology.

The importance of value, cost-effectiveness and quality has become even more apparent to me through completion of a European Heart Academy-sponsored MSc in Health Economics, Outcomes and Management in Cardiovascular Sciences, run jointly with the London School of Economics (LSE).

On Friday, two leaders from the MSc course will be involved in a joint session with LSE (11:30 – 12:30; Sala Darsena). Doctor Rocco Friebel will discuss research designs that can be used to demonstrate quality and value, which often differ from those we generally use, such as typical randomised controlled trials. Doctor Miqdad Asaria will then give a specific presentation about the cost-effectiveness of CMR in healthcare. We have an international panel who will talk through the ideas presented and discuss issues including differences in reimbursement and CMR activities around the world.

In order that we can extend our own thinking about how to enhance quality, build evidence and explore new areas, we are delighted to welcome Doctor Stuart Firestein, a neuroscientist from Columbia University (Columbia, New York, USA) who has authored the books, ‘Ignorance: How it Drives Science’ and ‘Failure: Why Science Is So Successful.’ As well as speaking at the Inaugural Session (Thursday: 17:05 – 18:05; Sala Grande), Dr. Firestein will lead a discussion at an EACVI Heart Imagers of Tomorrow symposium involving a panel of very highly experienced researchers who will speak about their own personal experiences of where ignorance and failure have provided important learnings (Friday: 09:35 –10:50; Course Room).”

“In the CMR community, we should consider the gaps in our knowledge to stimulate us to think about the next steps to providing further evidence.”

“If we can identify the uncertainties, then we can begin to address them, find solutions and ultimately, improve the care of our patients.”

 

Don’t miss!

Opening plenary: Quality through evidence and CMR innovation

Friday 08:30 – 09:30; Sala Grande